Implementing clinical trials on an international platform: Challenges and perspectives

[1]  S. Yusuf.  Damage to important clinical trials by over-regulation , 2010, Clinical trials.

[2]  M. Pencina,et al.  Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent , 2010, American heart journal.

[3]  Abdel Babiker,et al.  Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health , 2010, Clinical trials.

[4]  F. Zannad,et al.  Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011. , 2010, Therapie.

[5]  I. Cockburn,et al.  Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases , 2010, Clinical trials.

[6]  R. Conwit,et al.  Erratum to “The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial” [J. Neuroimmunol. 201–202(2008)80–84] , 2009, Journal of Neuroimmunology.

[7]  K. Huemer,et al.  Common definition for categories of clinical research: a prerequisite for a survey on regulatory requirements by the European Clinical Research Infrastructures Network (ECRIN) , 2009, Trials.

[8]  M. Sydes,et al.  International collaboration is feasible in trials for rare conditions: the EURAMOS experience. , 2007, Cancer treatment and research.

[9]  J. Provencio.  Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II) , 2009 .

[10]  R. Conwit,et al.  The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial , 2008, Journal of Neuroimmunology.